A Real-World Evidence Study of CDK4/6 Inhibitor Treatment Patterns and Outcomes in Metastatic Breast Cancer by Germline BRCA Mutation Status

被引：0
作者：
Jenna M. Collins
Beth L. Nordstrom
Kimmie K. McLaurin
Tapashi B. Dalvi
Susan C. McCutcheon
James C. Bennett
Brian R. Murphy
Puneet K. Singhal
Charles McCrea
Reshma Shinde
Josefa M. Briceno
机构：
[1] Evidera,
[2] AstraZeneca Pharmaceuticals,undefined
[3] LP,undefined
[4] AstraZeneca,undefined
[5] Merck & Co.,undefined
[6] Inc.,undefined
来源：
Oncology and Therapy | 2021年 / 9卷
关键词：
CDK4/6 inhibitors; g; mutation status; Metastatic breast cancer; Survival; Treatment patterns;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：575 / 589
页数：14
相关论文
共 112 条
[51]  
Mavaddat N(undefined)undefined undefined undefined undefined-undefined
[52]  
Barrowdale D(undefined)undefined undefined undefined undefined-undefined
[53]  
Andrulis IL(undefined)undefined undefined undefined undefined-undefined
[54]  
Aleskandarany M(undefined)undefined undefined undefined undefined-undefined
[55]  
Caracappa D(undefined)undefined undefined undefined undefined-undefined
[56]  
Nolan CC(undefined)undefined undefined undefined undefined-undefined
[57]  
Shah PD(undefined)undefined undefined undefined undefined-undefined
[58]  
Patil S(undefined)undefined undefined undefined undefined-undefined
[59]  
Dickler MN(undefined)undefined undefined undefined undefined-undefined
[60]  
Offit K(undefined)undefined undefined undefined undefined-undefined
12345678910